Olympus
7733.TPrecision Instruments
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥1.01T | ¥997.3bn | ¥925.8bnr | ¥881.9bn | ¥750.1bnr | ¥730.5bn |
| Operating income | ¥97.1bn | ¥162.5bn | ¥51.4bnr | ¥186.6bn | ¥146.2bnr | ¥82.0bn |
| Net income (owners) | ¥68.2bn | ¥117.9bn | ¥242.6bn | ¥143.4bn | ¥115.7bn | ¥12.9bn |
| Total assets | ¥1.54T | ¥1.43Tr | ¥1.53T | ¥1.51Tr | ¥1.36T | ¥1.18T |
| Net assets / equity | ¥812.0bn | ¥751.7bn | ¥757.2bn | ¥641.2bn | ¥511.4bn | ¥395.5bn |
| Operating cash flow | ¥100.6bn | ¥190.5bn | ¥42.4bn | ¥98.5bn | ¥169.7bn | ¥124.1bn |
| EPS (basic) | ¥61.32 | ¥102.99 | ¥199.91 | ¥113.22 | ¥90.22 | ¥10.05 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 82 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 80 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | Profit |
|---|---|
| Gastrointestinal Solutions | ¥136.4bn |
| Surgical And Interventional Solutions | −¥15.0bn |
| Other segments | −¥499m |
| Adjustments & eliminations | −¥23.8bn |
| Total | ¥121.4bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.